The spatial interaction index should quantify nearest-neighbor distances and interface lengths between CD8+ T cells, PD-L1+ tumor/myeloid cells, and CAF corridors, because diffuse tumor–immune mixing versus focal or peritumoral restriction carries distinct therapeutic implications in ovarian cancer (82–84). The gene discussed is CD8A; the disease is ovarian carcinoma.